STAAR SURGICAL CO
STAANasdaq
$26.44
↓ -8.8%Jul 17 close · end-of-day
Price
1Y↑ +54.7%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.3B
Enterprise Value
$1.2B
P/E
—
P/S
4.6
P/B
3.8
EV/EBITDA
—
PEG
—
FCF Yield
-4.1%
Dividend Yield
—
Revenue (TTM)
$290.4M
Net Income (TTM)
-$21.0M
Free Cash Flow (TTM)
-$55.0M
Gross Margin
76.9%
Operating Margin
-9.1%
Net Margin
-7.2%
ROE
-6.0%
ROIC
-11.0%
Debt / Equity
—
Net Cash
$163.9M
Return 1Y
+53.1%
Company profile
STAAR Surgical Company designs, develops, manufactures, markets, and sells implantable lenses for the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems.
- CEO
- Caren L. Mason
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 960
- Headquarters
- California
- Website
- staar.com
Management & directors
- Andrews Deborah JInterim Co-CEO and CFO
- Foust WarrenInterim Co-CEO and Pres. & COO
- Michna MagdaChief Development Officer
- Sisitsky NathanielChief Legal Officer
Roles derived from SEC Form 4 filings.
Earnings
STAA Q1 2026 Earnings
Period ends 2026-04-03
MetricActualYoY
Revenue$93.5M↑ +119.6%
Diluted EPS$0.10↓ -109.1%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2021 | FY2021 | FY2022 | FY2023 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $163.5M | — | $230.5M | $239.4M | $322.4M | — | $313.9M | $239.4M |
| Gross profit | $118.4M | — | $178.6M | $223.4M | $252.7M | — | $239.6M | $182.4M |
| Operating income | $6.8M | — | $33.3M | $43.8M | $28.1M | — | -$12.6M | -$91.7M |
| Net income | $5.9M | $27.5M | $27.5M | $39.7M | $21.3M | $21.3M | -$20.2M | -$80.4M |
| Diluted EPS | $0.12 | $0.56 | $0.56 | $0.80 | $0.43 | — | -$0.41 | -$1.62 |
| Operating cash flow | $21.0M | — | $44.0M | $35.7M | $14.6M | — | $15.7M | -$34.2M |
| Free cash flow | $12.5M | — | $30.3M | $17.6M | -$3.6M | — | -$7.7M | -$40.0M |
| Gross margin | 72.4% | — | 77.5% | 93.3% | 78.4% | — | 76.3% | 76.2% |
| Operating margin | 4.1% | — | 14.5% | 18.3% | 8.7% | — | -4.0% | -38.3% |
| Net margin | 3.6% | — | 11.9% | 16.6% | 6.6% | — | -6.4% | -33.6% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '26 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $99.0M | $88.6M | $49.0M | $42.6M | $44.3M | $94.7M | $57.8M | $93.5M |
| Gross profit | $78.4M | $68.5M | $31.6M | $28.0M | $32.8M | $77.9M | $43.7M | $68.9M |
| Operating income | $11.9M | $5.7M | -$27.9M | -$57.4M | -$30.0M | $18.5M | -$22.8M | $8.0M |
| Net income | $7.4M | $10.0M | -$34.2M | -$54.2M | -$16.8M | $8.9M | -$18.3M | $5.2M |
| Diluted EPS | $0.15 | $0.20 | -$0.69 | -$1.10 | -$0.34 | $0.18 | -$0.36 | $0.10 |
| Operating cash flow | -$10.4M | $3.8M | $642,000.00 | -$5.7M | -$27.2M | $2.7M | -$3.9M | -$21.7M |
| Free cash flow | -$16.6M | -$2.4M | -$5.1M | -$7.2M | -$29.0M | $1.8M | -$5.6M | -$22.1M |
| Gross margin | 79.2% | 77.3% | 64.7% | 65.8% | 74.0% | 82.2% | 75.7% | 73.6% |
| Operating margin | 12.0% | 6.4% | -57.0% | -134.8% | -67.6% | 19.5% | -39.5% | 8.5% |
| Net margin | 7.5% | 11.3% | -69.9% | -127.3% | -37.9% | 9.4% | -31.7% | 5.6% |
Company news
Jul 17, 2026
- 2d agoSTAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Knowfinance.yahoo.com
- 3d agoStocks Tumble as the Rout in Chipmakers Deepensbarchart.com
- 3d ago3 Unprofitable Stocks with Questionable Fundamentalsfinance.yahoo.com
- 3d agoStaar Surgical China Turnaround Continues to Boost Confidence, Wedbush Saysfinance.yahoo.com
Jul 16, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-18 | Butcher Arthur C | Option exercise | 5,341 | $0.00 | $0.00 | filing |
| 2026-06-18 | SILVERMAN LOU | Option exercise | 10,683 | $0.00 | $0.00 | filing |
| 2026-06-18 | Jiang Wei | Option exercise | 10,683 | $0.00 | $0.00 | filing |
| 2026-06-12 | Zhou Lilian Yansheng | Award | 3,530 | $28.29 | $99,865.11 | filing |
| 2026-05-15 | Foust Warren· Interim Co-CEO and Pres. & COO | Tax withholding | 7,460 | $32.07 | $239,242.20 | filing |
| 2026-05-15 | Michna Magda· Chief Development Officer | Tax withholding | 5,595 | $32.07 | $179,431.65 | filing |
| 2026-05-15 | ANDREWS DEBORAH J· Interim Co-CEO and CFO | Tax withholding | 3,755 | $32.07 | $120,422.85 | filing |
| 2026-05-15 | Foust Warren· Interim Co-CEO and Pres. & COO | Tax withholding | 3,730 | $32.07 | $119,621.10 | filing |
| 2026-05-15 | Foust Warren· Interim Co-CEO and Pres. & COO | Tax withholding | 3,730 | $32.07 | $119,621.10 | filing |
| 2026-05-15 | Michna Magda· Chief Development Officer | Tax withholding | 2,431 | $32.07 | $77,962.17 | filing |
| 2026-05-15 | ANDREWS DEBORAH J· Interim Co-CEO and CFO | Tax withholding | 1,877 | $32.07 | $60,195.39 | filing |
| 2026-05-15 | Foust Warren· Interim Co-CEO and Pres. & COO | Tax withholding | 1,865 | $32.07 | $59,810.55 | filing |
| 2026-05-15 | Michna Magda· Chief Development Officer | Tax withholding | 1,118 | $32.07 | $35,854.26 | filing |
| 2026-05-15 | Michna Magda· Chief Development Officer | Tax withholding | 559 | $32.07 | $17,927.13 | filing |
| 2026-05-15 | Michna Magda· Chief Development Officer | Award | 10,997 | $0.00 | $0.00 | filing |
| 2026-05-15 | ANDREWS DEBORAH J· Interim Co-CEO and CFO | Award | 10,466 | $0.00 | $0.00 | filing |
| 2026-05-15 | Michna Magda· Chief Development Officer | Award | 5,499 | $0.00 | $0.00 | filing |
| 2026-05-15 | Michna Magda· Chief Development Officer | Award | 2,199 | $0.00 | $0.00 | filing |
| 2026-05-15 | Michna Magda· Chief Development Officer | Award | 1,100 | $0.00 | $0.00 | filing |
| 2026-05-15 | Foust Warren· Interim Co-CEO and Pres. & COO | Award | 14,662 | $0.00 | $0.00 | filing |
| 2026-05-15 | Foust Warren· Interim Co-CEO and Pres. & COO | Award | 7,331 | $0.00 | $0.00 | filing |
| 2026-05-15 | Foust Warren· Interim Co-CEO and Pres. & COO | Award | 7,331 | $0.00 | $0.00 | filing |
| 2026-05-15 | ANDREWS DEBORAH J· Interim Co-CEO and CFO | Award | 5,233 | $0.00 | $0.00 | filing |
| 2026-05-15 | Foust Warren· Interim Co-CEO and Pres. & COO | Award | 3,666 | $0.00 | $0.00 | filing |
| 2026-05-08 | Foust Warren· Interim Co-CEO and Pres. & COO | Tax withholding | 3,448 | $26.69 | $92,027.12 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.